London-based investment platform HANetf has launched Switzerland’s first medical cannabis ETF as one of five new products on the Swiss Stock Exchange, in a further expansion of the company’s pan-European distribution capabilities.
According to Swiss stock exchange operator SIX, the ETFs enable investors to diversify their portfolios by incorporating “promising” megatrends, with the focus of the ETFs covering e-commerce, cloud technologies, medical cannabis and wellness.
The Medical Cannabis & Wellness UCITS ETF (CBDX) – provides exposure to companies involved in the legal medical cannabis, hemp and CBD sectors. The fund tracks a rules-based Medical Cannabis and Wellness Equity Index from Solactive, consisting of publicly listed companies conducting legal business activities across nine thematic sub-sectors in the medical cannabis, hemp and CBD industries.
The fund seeks to provide targeted exposure to the rapidly expanding legal medical cannabis industry that is set for further growth as more countries legalise cannabis for medical use.
The underlying indices reflect stocks which target long-term, social and technological megatrends. HANetf co-founder and chief executive Hector McNeill said: “We see megatrend ETFs as being particularly well suited to the Swiss wealth management market as they are typically highly differentiated and target long-term social or technological trends that have seen high growth in recent years.”
Data from SIX shows that its ETF segment registered a trading turnover of more than 50 billion Swiss francs (€46.8 billion) during the first four months this year – a year-on-year growth of 46%.
Source | HANetf